A detailed history of Dimensional Fund Advisors LP transactions in A Ikido Pharma Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 39,833 shares of AIKI stock, worth $151,365. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,833
Previous 39,833 -0.0%
Holding current value
$151,365
Previous $151,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
N/A
2,457 Added 6.57%
39,833 $151,000
Q4 2023

Feb 07, 2024

SELL
N/A
-2,213 Reduced 5.59%
37,376 $142,000
Q3 2023

Nov 09, 2023

SELL
N/A
-18,416 Reduced 31.75%
39,589 $150,000
Q2 2023

Aug 09, 2023

SELL
N/A
-8,670 Reduced 13.0%
58,005 $220,000
Q4 2022

Feb 09, 2023

BUY
$3.07 - $7.21 $27,095 - $63,635
8,826 Added 15.26%
66,675 $218,000
Q3 2022

Nov 10, 2022

BUY
$5.6 - $7.03 $67,821 - $85,140
12,111 Added 26.48%
57,849 $396,000
Q2 2022

Aug 12, 2022

BUY
$4.59 - $7.99 $209,937 - $365,446
45,738 New
45,738 $269,000

Others Institutions Holding AIKI

About AIkido Pharma Inc.


  • Ticker AIKI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,485,100
  • Market Cap $20.8M
  • Description
  • AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small mo...
More about AIKI
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.